Antibody Modeler and Antibody Structure Database.

Protein Sidechain Database for homology modeling, rotamer exploration and mutation. SAReport for web-based scaffold detection and SAR analysis. Molecule Fragment Generator and 800,000 compound 3D Scaffold Database. 3D Ligand Generator (BREED) with receptor scoring.

Ray Tracer interface and Movie Maker for publication quality graphics. “We are very excited about the 2008 release of MOE. A key focus for us has been in antibody modeling and we have produced the industry’s leading antibody modeling technology. Many pharmaceutical and biotechnology companies consider antibody therapeutics as a vital component of their product development strategy and CCG’s technology will help them speed up their discovery process,” said Paul Labute, President and CEO of CCG.

Labute went on to say that, “CCG has also created several new applications for small molecule drug discovery. Of particular importance is a web-based application called SAReport for the visualization and analysis of project SAR data. SAReport contains sophisticated analysis methods to help scientists identify important groups and make more effective choices for synthesis. As experimental data builds up on discovery projects it is often difficult for scientists and managers to keep track of the information. SAReport puts the information into a consistent context for better decision making.”

CCG has a long track record of scientific innovation and believes that its decade of continuous growth is a direct result of its strong focus on research and collaborative customer support. CCG has recently expanded its Research and Support groups and looks forward to its increased capacity to provide customers with leading-edge software applications and to support their discovery efforts.